GSK plc, Biocare Medical LLC, Teva Pharmaceuticals Industries, Mitsubishi chemical group corporation, Bristol-Myers Squibb Company in the Anxiety Disorder Treatment market. In 2023, the Anxiety ...

Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

DelveInsight's Glucose Syrup Market Insights report provides the current and forecast market analysis, individual leading ...

FIRST IN PI: With Donald Trump cruising to a second term in the White House in part by eschewing traditional media outlets in favor of the podcast circuit, a progressive public affairs firm is warning ...

The glucose syrup market is largely driven by its rising demand within the food and beverage industry. Furthermore, the expanding uses and benefits of glucose syrup in the pharmaceutical sector ...

It stands out in a region where Amish farms and hills covered with second-growth red-oak woods, parks, and hiking trails alternate with post-World-War II factories, including GlaxoSmithKline’s new ...

Several factors, including interest rate reductions, strong market performance and an incoming U.S. governmental ...

GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...